Exercise-induced physiological stress. Drug or medicament, unspecified
Conditions
Interventions
The subjects in Ubiquinone group will intake 5 mg/kg/day Ubiquinone plus 6 mg/kg/day maltodexterine for 2 weeks (11 sessions).
Intervention 1: The subjects in placebo group will intake 11 mg/kg/day maltodexterine for 2 weeks (11 sessions). Intervention 2: The subjects in Ubiquinone group will intake 5 mg/kg/day Ubiquinone plu
Placebo
Treatment - Drugs
The subjects in CaQ10 group will intake 6 mg/kg/day Caffeine plus 5 mg/kg/day Ubiquinone for 2 weeks (11 sessions).
Sponsors
University of Tabriz
Eligibility
Sex/Gender
Female
Age
20 Years to 28 Years
Inclusion criteria
Inclusion criteria: Inclusion: Female; 20-28 year; healthy; Aerobics athletes; BMI 100 mg/day (during 6 months prior to the study) Exclusion: Diseases; Injuries; Uncontrolled intake of anti-inflammatory drugs during the period; Uncontrolled intake of stimulants during the period;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malondialdehyde. Timepoint: 30 minutes before first Aerobics session; 30 minutes before last Aerobics session; and 18- 24 hours after supplementation and training protocol. Method of measurement: spectrophotometry.;Anti-oxidant capacity. Timepoint: 30 minutes before first Aerobics session; 30 minutes before last Aerobics session; and 18- 24 hours after supplementation and training protocol. Method of measurement: ferric reducing ability of plasma (frap). | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Temperature. Timepoint: 30 minutes before every training session. Method of measurement: Thermometer.;Blood Presure. Timepoint: 30 minutes before every trainig session. Method of measurement: Aneroid blood pressure measurement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Afshar Jafari
University of Tabriz
Outcome results
None listed